subtyp
specif
influenza
viru
iav
determin
two
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
ha
distinct
subtyp
exist
nine
exist
na
epidem
strain
iav
chang
frequent
caus
annual
season
epidem
well
occasion
pandem
notori
influenza
pandem
recent
introduct
pandem
iav
viru
human
reemphas
public
health
concern
iav
sever
studi
identifi
conserv
epitop
within
specif
ha
subtyp
use
diagnost
howev
immun
specif
epitop
iav
complet
assess
studi
linear
epitop
viral
ha
protein
identifi
peptid
scan
use
librari
overlap
peptid
convalesc
sera
patient
one
epitop
aa
found
immunodomin
patient
evok
high
titer
antibodi
mice
multipl
sequenc
align
silico
coverag
analysi
show
epitop
highli
conserv
influenza
ha
coverag
almost
complet
absent
subtyp
coverag
previous
unidentifi
linear
epitop
locat
outsid
five
wellrecogn
antigen
site
ha
peptid
elisa
method
base
epitop
develop
show
high
correl
x
pearson
correl
coeffici
r
hemagglutin
inhibit
test
highli
conserv
subtypespecif
immunodomin
epitop
may
form
basi
develop
novel
assay
serodiagnosi
activ
surveil
iav
influenza
virus
iav
member
orthomyxovirida
famili
highli
contagi
varieti
avian
mammalian
speci
iav
caus
season
influenza
epidem
annual
recur
pandem
sever
consequ
public
health
global
economi
least
three
iavpandem
emerg
last
centuri
spanish
flu
seriou
influenza
pandem
kill
million
peopl
worldwid
latter
two
pandem
although
mild
compar
incid
result
signific
mortal
close
million
million
death
respect
latest
pandem
influenza
newest
global
health
challeng
occur
due
emerg
pandem
iav
viru
viru
detect
countri
territori
caus
death
juli
viral
genom
iav
consist
eight
singlestrand
neg
sens
rna
segment
encod
least
viral
protein
includ
two
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
base
antigen
properti
ha
na
iav
classifi
ha
subtyp
na
subtyp
ha
subtyp
identifi
avian
speci
ha
subtyp
known
infect
human
be
subtyp
caus
pandem
also
domin
season
epidem
togeth
influenza
b
viru
ha
encod
segment
iav
genom
glycoprotein
approxim
amino
acid
biolog
activ
ha
homolog
trimer
molecul
attach
virion
membran
carboxi
terminu
ha
play
critic
role
pathogenesi
iav
ha
mediat
iav
bind
cellular
receptor
nacetylneuramin
sialic
acid
well
subsequ
membran
fusion
process
ha
also
stimul
host
protect
immun
specif
product
neutral
antibodi
gener
antiha
neutral
antibodi
major
target
influenza
vaccin
develop
due
specif
immun
respons
ha
also
import
target
iav
subtyp
use
immunoassay
activ
serolog
surveil
viral
antibodi
great
import
influenza
control
prevent
sever
iav
subtypespecif
serolog
test
develop
present
subtyp
iav
mainli
reli
hemagglutin
inhibit
hi
test
use
ha
na
subtypespecif
refer
sera
howev
number
drawback
hi
test
assay
rel
labori
low
sensit
requir
prepar
antigen
viabl
virus
potenti
hazard
contain
low
signal
nois
ratio
eg
assay
exhibit
intervari
subtyp
crossreact
moreov
hi
test
confound
steric
hindranc
na
antibodi
lead
nonspecif
inhibit
misidentif
microneutr
test
altern
method
type
subtyp
influenza
virus
howev
due
need
cell
cultur
process
method
laborintens
requir
biolog
safeti
contain
particularli
high
pathogen
strain
suitabl
larg
scale
investig
recent
subtyp
iav
antibodi
use
differ
categori
elisa
assay
also
report
howev
present
elisa
assay
mainli
reli
ha
antigen
lead
nonspecif
detect
extent
due
possibl
crossreact
differ
subtyp
virusderiv
epitop
use
tool
accur
evalu
immun
respons
differenti
respons
specif
due
crossreact
sever
studi
report
exist
ha
subtypespecif
well
inter
subtypeconserv
epitop
elisa
assay
base
epitop
highli
conserv
specif
one
certain
ha
subtyp
use
rapid
simpl
subtyp
iav
epitop
iav
fulli
address
although
mani
studi
perform
present
studi
report
success
identif
new
epitop
highli
conserv
among
major
iav
strain
subtyp
moreov
develop
elisa
assay
antibodi
subtyp
base
epitop
result
deriv
new
assay
correl
result
obtain
use
hi
test
identifi
immunodomin
epitop
ha
protein
peptid
scan
assay
perform
set
peptid
five
residu
overlap
adjac
peptid
span
ectodomain
sequenc
ha
protein
viru
strain
synthes
bind
peptid
convalesc
serum
sampl
patient
examin
elisa
use
peptid
coat
antigen
five
peptid
found
react
well
sera
test
peptid
correspond
sequenc
amino
acid
aa
residu
ha
molecul
respect
fig
tabl
among
peptid
react
sera
peptid
react
sera
peptid
react
sera
data
indic
peptid
may
contain
viru
b
cell
epitop
visual
locat
peptid
ha
protein
map
peptid
crystal
model
protein
fig
variou
color
figur
repres
differ
peptid
although
residu
indic
blue
residu
indic
red
part
primari
sequenc
locat
middl
helix
b
trimer
structur
partial
surfac
expos
residu
indic
magenta
seem
dispatch
link
stem
region
globular
region
fulli
surfac
expos
fig
residu
indic
orang
locat
receptor
bind
domain
confirm
immunogen
peptid
vivo
analyz
sera
deriv
peptideimmun
mice
five
posit
peptid
two
control
peptid
coupl
keyhol
limpet
hemocyanin
klh
use
immun
balbc
mice
tabl
antisera
collect
five
day
third
immun
titrat
elisa
use
correspond
peptid
coat
antigen
result
show
peptid
conjug
except
induc
potent
antibodi
titer
endpoint
titer
antisera
elisa
mice
immun
peptid
respect
fig
data
indic
posit
peptid
elicit
humor
immun
highli
immunogen
mice
confirm
antibodi
recogn
ha
antigen
reactiv
antipeptid
sera
evalu
western
blot
elisa
purifi
protein
viru
data
demonstr
sera
control
react
protein
fig
sera
react
protein
although
exhibit
high
elisa
reactiv
protein
fig
taken
togeth
result
demonstr
peptid
contain
domin
epitop
viru
character
three
peptid
follow
studi
determin
epitop
identifi
studi
stimul
neutral
antibodi
hapseudotyp
neutral
test
perform
antipeptid
sera
use
pseudotyp
lentiviru
none
sera
could
effici
inhibit
inhibit
entri
ha
pseudotyp
figur
indic
epitop
contain
neutral
activ
western
blot
analysi
use
determin
specif
epitop
present
peptid
recombin
ha
protein
obtain
transient
express
correspond
gene
pcagg
vector
cell
lysat
cell
use
examin
specif
antibodi
elicit
peptideconjug
shown
fig
serum
react
includ
virus
ha
protein
sera
react
ha
protein
find
indic
may
contain
specif
epitop
evalu
subtypespecif
epitop
addit
ha
protein
three
epidem
human
strain
differ
year
well
swine
strain
express
pcagg
vector
cell
reactiv
sera
cell
lysat
determin
western
blot
analysi
result
show
serum
strongli
react
six
ha
protein
manner
similar
antibodi
viru
fig
found
sera
reactiv
weak
ha
protein
viru
strain
fig
data
indic
epitop
peptid
rel
conserv
among
iav
though
virus
circul
world
almost
centuri
test
sera
crossreact
influenza
type
b
viru
reactiv
sera
two
repres
influenza
type
b
viru
strain
yamagata
lineag
victoria
lineag
influenza
type
viru
strain
examin
western
blot
analysi
result
show
serum
react
well
viru
influenza
type
b
viru
strain
fig
confirm
specif
epitop
determin
conserv
identifi
epitop
among
iav
aa
sequenc
align
correspond
aa
sequenc
subtyp
avail
genbank
fig
repres
align
analysi
show
ident
ha
subtyp
strain
ident
ha
subtyp
well
highli
ident
ha
subtyp
data
consist
specif
analysi
western
blot
fig
although
antibodi
recogn
ha
similar
multipl
subtyp
assess
ident
level
sequenc
among
known
iav
strain
silico
coverag
analysi
perform
analysi
show
peptid
sequenc
could
identifi
ha
sequenc
avail
influenza
research
databas
http
wwwfludborg
tabl
notabl
sequenc
scarc
present
among
subtyp
iav
howev
despit
high
ident
ha
protein
peptid
sequenc
also
present
among
virus
taken
togeth
find
indic
peptid
specif
conserv
among
viru
strain
defin
epitop
contain
precis
peptideinhibit
elisa
perform
experi
reliabl
standard
methodolog
determin
fine
specif
antigenantibodi
reaction
panel
short
peptid
deriv
cterminu
truncat
nterminu
truncat
use
block
bind
antibodi
coat
shown
fig
antibodi
induc
conjug
inhibit
peptid
parent
peptid
similar
extent
wherea
peptid
show
ineffici
inhibit
even
high
molar
concentr
similar
pattern
inhibit
observ
ctermin
conserv
deriv
peptid
parent
peptid
demonstr
compar
effici
inhibit
wherea
slight
inhibit
observ
peptid
fig
sinc
amino
acid
sequenc
lrgvapl
overlap
peptid
fig
specul
sequenc
met
minimum
requir
bind
antibodi
howev
synthet
peptid
lrgvapl
block
bind
peptid
antibodi
directli
bind
antibodi
fig
swine
strain
cell
transfect
empti
vector
use
control
ctrl
bactin
use
load
control
background
variou
subtyp
iav
strain
see
inspir
high
specif
among
virus
develop
indirect
elisa
assay
use
peptid
evalu
perform
diagnost
tool
antibodi
hi
test
use
refer
method
shown
tabl
overal
agreement
two
method
show
two
method
good
correl
pearson
correl
coeffici
r
sensit
specif
peptideelisa
versu
hi
test
respect
indic
potenti
peptideelisa
method
detect
antibodi
iav
present
studi
identifi
immunodomin
linear
b
cell
epitop
viru
ha
protein
peptid
scan
approach
use
patient
sera
confirm
unidentifi
epitop
highli
conserv
among
subtyp
virus
show
good
correl
result
obtain
use
hi
test
find
demonstr
potenti
epitopebas
antibodi
detect
iav
diagnosi
surveil
iav
escap
human
immun
system
continu
antigen
drift
occasion
antigen
shift
attempt
develop
univers
vaccin
reliabl
diagnost
tool
base
conserv
epitop
iav
big
challeng
sever
epitop
elicit
broad
spectrum
neutral
antibodi
identifi
recent
exampl
sui
et
al
identifi
univers
neutral
epitop
group
ha
yoshida
et
al
report
univers
epitop
antigen
site
b
share
subtyp
epitop
conformationdepend
studi
identifi
two
epitop
identifi
previous
fig
seem
dispatch
link
stem
region
globular
region
fulli
expos
surfac
aa
locat
middl
helix
b
contrast
previou
studi
found
linear
b
cell
epitop
data
demonstr
epitop
highli
conserv
among
virus
viral
mutant
resist
conform
epitop
easili
gener
conserv
linear
epitop
suitabl
differenti
subtyp
conform
epitop
henc
epitop
provid
new
target
reliabl
diagnost
iav
antigen
site
iav
ha
protein
subtyp
previous
character
sequenc
analysi
antigen
variant
amino
acid
substitut
previous
identifi
antigen
site
mainli
locat
globular
head
threedimension
structur
subunit
ha
molecul
instanc
five
antigen
site
identifi
ha
influenza
viru
wellknown
refer
strain
iav
recent
sever
epitop
identifi
unit
togeth
report
result
indic
epitop
imag
epitop
iav
need
character
differ
find
previous
identifi
epitop
explain
differ
screen
method
use
studi
other
previou
studi
monoclon
antibodi
murin
hybridoma
cell
use
identifi
antigen
site
studi
use
peptid
scan
approach
involv
overlap
peptid
librari
human
convalesc
antiseraa
strategi
wide
use
viral
epitop
identif
given
fact
viral
antigen
recycl
present
short
peptid
differ
conform
humor
immun
respons
short
peptid
select
b
cell
clone
convalesc
sera
patient
much
complex
monoclon
antibodi
mice
reflect
real
immun
respons
viral
infect
approach
add
avail
techniqu
current
use
identifi
linear
epitop
serolog
test
ha
pseudotyp
lentiviru
wide
appli
studi
neutral
antibodi
iav
use
method
evalu
epitop
identifi
studi
could
stimul
neutral
antibodi
data
show
epitop
could
elicit
neutral
antibodi
pseudovirion
neutral
assay
due
linear
natur
previou
studi
shown
neutral
epitop
conform
depend
length
b
cell
epitop
vari
amino
acid
map
epitop
contain
perform
peptideinhibit
elisa
use
seri
ntermin
ctermin
truncat
peptid
howev
found
fulllength
aa
length
rather
truncat
peptid
show
strongest
bind
correspond
antibodi
fig
fig
peptid
shortest
truncat
bind
antibodi
share
core
sequenc
lrgvapl
test
whether
sequenc
could
epitop
howev
synthet
peptid
lrgvapl
block
interact
bind
antibodi
fig
thu
specul
adjac
amino
acid
sequenc
also
involv
bind
antibodi
elicit
conjug
concept
use
linear
epitop
influenza
viru
diagnost
control
extens
investig
recent
studi
epitopeblock
elisa
univers
detect
antibodi
human
viru
develop
result
show
peptideelisa
base
highli
conserv
subtypespecif
epitop
also
use
detect
antibodi
display
good
correl
hi
test
result
indic
potenti
epitop
iav
diagnosi
howev
perform
assay
need
evalu
studi
larg
scale
sampl
conclus
data
provid
evid
subtyp
ha
harbor
epitop
found
previous
conserv
epitop
aa
ha
iav
near
complet
absenc
subtyp
indic
epitop
meet
critic
requir
diagnosi
subtyp
influenza
viru
infect
peptideelisa
develop
studi
may
applic
serodiagnosi
may
serv
univers
diagnost
tool
iav
surveil
screen
specif
epitop
set
peptid
span
amino
acid
sequenc
ha
protein
ectodomain
pandem
influenza
viru
strain
synthes
peptid
amino
acid
length
five
residu
overlap
adjac
peptid
fig
peptid
select
immun
experi
shown
tabl
peptid
conjug
carrier
protein
keyhol
limpet
hemocyanin
klh
sigma
st
loui
mo
improv
immunogen
water
solubl
peptid
low
conjug
klh
directli
peptid
first
link
acid
tripeptid
kkc
prior
conjug
klh
addit
famili
short
peptid
homolog
peptid
also
synthes
fine
map
epitop
contain
peptid
fig
peptid
conjug
use
studi
synthes
sangon
shanghai
biotechnol
co
ltd
shanghai
china
peptid
purifi
homogen
puriti
highperform
liquid
chromatographi
verifi
mass
spectrometri
refer
influenza
viru
strain
abbrevi
yamagata
lineag
abbrevi
victoria
lineag
abbrevi
bv
kindli
provid
beij
center
diseas
control
prevent
virus
grown
mdck
cell
describ
elsewher
titer
viru
strain
determin
hemagglutin
test
express
hemagglutin
unit
hau
western
blot
analysi
inactiv
virus
lyze
lysi
buffer
mm
trishcl
mm
nacl
mm
edta
tritonx
ph
supplement
proteas
inhibitor
cocktail
roch
indianapoli
serum
sampl
collect
convalesc
patient
earli
pandem
beij
diagnost
criteria
influenza
viru
infect
patient
fulli
follow
descript
sera
healthi
blood
donor
use
neg
control
addit
serum
sampl
collect
blood
donor
recruit
evalu
peptideelisa
assay
develop
studi
sampl
kindli
provid
beij
municip
center
diseas
control
prevent
beij
china
written
inform
consent
obtain
particip
sampl
code
prior
analysi
ensur
anonym
procedur
approv
institut
medic
ethic
review
board
institut
pathogen
biolog
chines
academi
medic
scienc
beij
china
fulllength
cdna
fragment
correspond
ha
subtyp
iav
insert
pcagg
vector
purchas
addgen
express
entir
ha
protein
unpublish
data
protein
ha
gene
repres
human
iav
strain
differ
year
swine
influenza
viru
strain
express
insert
correspond
cdna
fragment
pcagg
vector
similar
manner
detail
influenza
viru
strain
pleas
refer
fig
recombin
plasmid
transfect
cell
atcc
number
use
lipofectamin
invitrogen
carlsbad
ca
accord
manufactur
instruct
cell
harvest
lyze
hour
transfect
express
ha
protein
verifi
western
blot
analysi
use
murin
antibodi
correspond
protein
unpublish
data
reactiv
synthet
ha
peptid
purifi
protein
eenzym
llc
montgomeri
villag
md
convalescentphas
sera
patient
serum
sampl
mice
immun
peptid
conjug
determin
elisa
briefli
peptid
mgwell
protein
mgwell
use
coat
microtit
plate
corn
costar
acton
carbon
buffer
ph
overnight
block
bovin
serum
albumen
bsa
plate
incub
indic
dilut
serum
sampl
human
mous
hr
wash
four
time
pb
contain
tween
pbst
bound
igg
antibodi
detect
horseradish
peroxidas
hrp
conjug
goat
antihuman
igg
antimous
igg
sigma
hr
four
wash
pbst
reaction
visual
addit
substrat
tmb
sigma
color
develop
stop
addit
mlwell
sulphur
acid
min
optic
densiti
nm
od
nm
measur
elisa
plate
reader
molecular
devic
sunnyval
california
evalu
reactiv
short
peptid
antibodi
peptideinhibit
elisa
assay
perform
ad
dilut
peptid
constant
amount
antibodi
elicit
conjug
dilut
maximum
bind
antigenco
well
observ
absenc
peptid
inhibitor
antibodi
bound
express
percentag
maximum
level
bind
femal
balbc
mice
week
old
immun
subcutan
variou
peptideklh
conjug
mix
freund
complet
adjuv
sigma
mg
per
inject
boost
inject
given
interv
mg
antigen
freund
incomplet
adjuv
sigma
antibodi
collect
five
day
third
boost
anim
experi
carri
facil
institut
laboratori
anim
scienc
ila
chines
academi
medic
scienc
cam
experiment
procedur
approv
permit
number
supervis
anim
protect
usag
committe
ila
cam
hr
posttransfect
cell
transfect
haexpress
plasmid
harvest
pellet
lyze
lysi
buffer
mm
trishcl
mm
nacl
mm
edta
tritonx
ph
supplement
proteas
inhibitor
cocktail
roch
indianapoli
aliquot
cell
lysat
mg
viru
lysat
blot
sdspage
onto
nitrocellulos
membran
pall
port
washington
ny
membran
block
nonfat
milk
incub
primari
antibodi
indic
figur
overnight
follow
incub
goat
antimous
irdyeh
fluor
igg
secondari
antibodi
licor
lincoln
ne
wash
membran
scan
odysseyh
infrar
imag
system
licor
analyz
odyssey
softwar
molecular
size
develop
protein
determin
comparison
prestain
protein
marker
fermenta
maryland
ca
hi
test
carri
describ
elsewher
rde
treat
serum
sampl
inactiv
min
twofold
serial
dilut
initi
dilut
twenti
five
ml
dilut
serum
incub
ml
four
hemagglutin
unit
refer
influenza
strain
min
room
temperatur
refer
iav
strain
hi
test
respect
ml
chicken
erythrocyt
suspens
ad
well
incub
min
posit
reaction
record
hi
antibodi
titer
equal
greater
viru
pseudotyp
lentivirus
produc
cell
cotransfect
e
ha
na
construct
use
polyethylenimin
pei
base
transfect
protocol
cell
cultur
supernat
collect
hr
posttransfect
filter
mmpore
size
filter
millipor
billerica
use
pseudotyp
neutral
test
serum
sampl
heat
inactiv
min
dilut
cultur
medium
mix
equal
volum
dilut
influenza
pseudovirion
incub
hr
ml
pseudovirion
contain
ngml
hiv
gag
protein
serum
mixtur
ad
plate
contain
cell
grown
hr
initi
cell
infect
evalu
hr
postinfect
luciferas
assay
percentag
infect
pseudovirion
treat
test
serum
neg
serum
control
calcul
reduct
infect
serum
addit
consid
neutral
activ
test
run
least
duplic
assess
ident
ha
epitop
iav
silico
analysi
perform
util
bioinformat
tool
influenza
research
databas
http
wwwfludborg
two
program
use
studi
search
protein
sequenc
identifi
short
peptid
flu
protein
former
program
use
defin
number
total
sequenc
ha
protein
accord
subtyp
paramet
latter
program
defin
number
hit
total
sequenc
standard
evalu
short
peptid
sequenc
homolog
chose
fuzzi
match
analysi
repres
ident
level
peptid
sequenc
ha
protein
analysi
type
chosen
fuzzi
match
meant
charact
ident
search
aa
string
exampl
enter
gilgfvftl
may
also
find
ailgfvfti
aligfvfsi
pearson
correl
coeffici
calcul
pearson
chi
squar
test
crosstab
tabl
use
spss
softwar
sensit
specif
peptideelisa
versu
hi
test
determin
roc
curv
analysi
use
spss
softwar
figur
local
comparison
identifi
peptid
classic
five
antigen
site
stereo
view
ha
monom
surfac
view
influenza
viru
pdb
shown
color
illustr
five
antigen
site
sa
sb
cb
identifi
peptid
membran
distal
proxim
blue
red
black
cb
green
magenta
rainbow
sa
yellow
sb
cyan
tif
